Blue Cross of Idaho Logo

Express Sign-on

Thank you for registering with Blue Cross of Idaho

If you are an Individual or Family Member under age 65, please register here.

If you are an Medicare or Medicare Supplement member, please register here.

New Options for Affordable Health Insurance
MP 1.01.05

Ultrasound Accelerated Fracture Healing Device


Medical Policy    
Section
Durable Medical Equipment
 
Original Policy Date
12/1/95

Last Review Status/Date
Reviewed with literature search/12:2012

Issue

12:2012

  Return to Medical Policy Index

Disclaimer

Our medical policies are designed for informational purposes only and are not an authorization, or an explanation of benefits, or a contract.  Receipt of benefits is subject to satisfaction of all terms and conditions of the coverage.  Medical technology is constantly changing, and we reserve the right to review and update our policies periodically. 


Description

Low-intensity pulsed ultrasound has been investigated as a technique to accelerate healing of fresh fractures, delayed unions, and nonunions. Ultrasound is delivered with the use of a transducer applied to the skin surface overlying the fracture site.

Ultrasound treatment can be self-administered with one daily 20-minute treatment, continuing until the fracture has healed. The mechanism of action at the cellular level is not precisely known but is thought to be related to a mechanical effect on cell micromotion/deformation, causing an increase in stimulation of transmembrane cell adhesion molecules and upregulation of cyclooxygenase-2.

Regulatory Status

The Sonic Accelerated Fracture Healing System, SAFHS® (also referred to as Exogen 2000®) was initially cleared for marketing by the U.S. Food and Drug Administration (FDA) in October 1994 as a treatment of fresh, closed, posteriorly displaced distal radius (Colles’) fractures and fresh, closed, or grade-I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopedically managed by closed reduction and cast immobilization. In February 2000, the labeled indication was expanded to include the treatment of established nonunions, excluding skull and vertebra. According to the FDA labeling, a nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.


Policy

Low-intensity ultrasound treatment may be considered medically necessary when used as an adjunct to conventional management (i.e., closed reduction and cast immobilization) for the treatment of fresh, closed fractures in skeletally mature individuals. Candidates for ultrasound treatment are those at high risk for delayed fracture healing or nonunion. These risk factors may include either locations of fractures or patient comorbidities and include the following:

Patient comorbidities:

  • Diabetes
  • Steroid therapy
  • Osteoporosis
  • History of alcoholism
  • History of smoking

Fracture locations:

  • Jones fracture
  • Fracture of navicular bone in the wrist (also called the scaphoid)
  • Fracture of metatarsal
  • Fractures associated with extensive soft tissue or vascular damage

Low-intensity ultrasound treatment may be considered medically necessary as a treatment of delayed union of bones, excluding the skull and vertebra. (See Policy Guidelines for definition of delayed union.)

Low-intensity ultrasound treatment may be considered medically necessary as a treatment of fracture nonunions of bones, excluding the skull and vertebra. (See Policy Guidelines for definition of nonunion.)

Other applications of low-intensity ultrasound treatment are investigational, including, but not limited to, treatment of congenital pseudarthroses, open fractures, stress fractures, arthrodesis or failed arthrodesis.


Policy Guidelines 

Fresh (Acute) Fracture

A fracture is most commonly defined as “fresh” for 7 days after the fracture occurs. Most fresh closed fractures heal without complications with the use of standard fracture care, i.e., closed reduction and cast immobilization.

Delayed Union

Delayed union is defined as a decelerating healing process as determined by serial x-rays, together with a lack of clinical and radiologic evidence of union, bony continuity, or bone reaction at the fracture site for no less than 3 months from the index injury or the most recent intervention.

Nonunion

There is not a consensus for the definition of nonunions. One proposed definition is failure of progression of fracture-healing for at least 3 consecutive months (and at least 6 months following the fracture) accompanied by clinical symptoms of delayed/nonunion (pain, difficulty weight bearing). (1)

The definition of non-union in the FDA labeling suggests that nonunion is considered established when the fracture site shows no visibly progressive signs of healing, without giving any guidance regarding the timeframe of observation. However, it is suggested that a reasonable time period for lack of visible signs of healing is 3 months. The following patient selection criteria are consistent with those proposed for electrical stimulation as a treatment of nonunions (see policy No. 7.01.07):

  • At least 3 months have passed since the date of the fracture, AND
  • serial radiographs have confirmed that no progressive signs of healing have occurred, AND
  • the fracture gap is 1 cm or less, AND
  • the patient can be adequately immobilized and is of an age when he/she is likely to comply with non-weight bearing.

Benefit Application
BlueCard/National Account Issues

State or federal mandates (e.g., FEP) may dictate that all FDA-approved devices, drugs or biologics may not be considered investigational and thus these devices may be assessed only on the basis of their medical necessity.

The transducer used for ultrasound treatment is categorized as a piece of durable medical equipment.


Rationale 

This policy was initially developed in December 1995. Since that time, the policy has been updated on a regular basis using MEDLINE literature searches. The most recent literature search was conducted using MEDLINE from August 2011 through July 2012.

Literature Review

Fresh Fractures

The policy regarding fresh fractures is based in part on a 1995 TEC Assessment that concluded that ultrasound fracture healing met the TEC criteria for the indications labeled by the U.S. Food and Drug Administration (FDA) as a treatment of closed, fresh fractures of the tibial or distal radius (i.e., Colles’) fractures. (2) Since the TEC Assessment, there have been numerous randomized controlled trials (RCTs) and systematic reviews of clinical trials on the use of ultrasound to improve healing in fresh fractures.

Systematic Reviews. A 2002 meta-analysis conducted by Busse and colleagues (3) supported the use of low-intensity ultrasound as a technique for fractures treated nonoperatively. This systematic review was updated in 2009 and included RCTs of low-intensity pulsed ultrasonography for any type of fracture. (4) Thirteen trials were included; in 5 of them, patients were managed conservatively, and in 8 studies, patients had ultrasound therapy after operative management (distraction osteogenesis in 3 studies, bone graft for nonunion in 1, and operative treatment of fresh fractures in 4). Ultrasound therapy significantly accelerated radiographic healing of fractures in all 3 RCTs of conservatively managed fresh fractures that assessed this outcome. (These trials are described in more detail below.)

The trials of operatively managed (open) fresh fractures outcomes were inconsistent; 4 trials provided low-quality evidence for acceleration of healing by ultrasound therapy. Pooled results of 2 trials showed a non-significant mean reduction in radiographic healing time of 16.6%.

A 2012 Cochrane review on ultrasound and shockwave therapy included 11 studies on ultrasound; 8 of the studies were randomized controlled trials. (5) The included studies were limited in methodologic quality, with all having some evidence of bias. There was very limited evidence on functional outcomes, and the available data showed no significant difference between ultrasound and placebo control on functional outcomes. There was a significant effect of ultrasound on time to healing when all types of fractures were pooled (standardized mean difference -0.69, [95% confidence interval (CI): -1.31 to -0.07]). This effect on time to healing was not present when upper or lower limb fractures were examined separately and was not robust in sensitivity analyses performed as a “worst case analysis”. There was also no significant treatment effect found in pooled analyses for treatment of nonunion or delayed union. This review did not distinguish between closed and open fractures.

RCTs of Closed Fractures. In a 1997 multicenter RCT by Kristiansen et al., 60 patients with dorsally angulated fractures of the distal radius treated with manipulation and cast were randomly assigned to 10 weeks of daily treatment with a pulsed ultrasound device or an inactive device. (6) All patients started ultrasound within 7 days after having sustained the fracture. Blinded radiographic and clinical examinations showed faster healing in the ultrasound group (61 days) than in the control group (98 days) (p<0.001). Each radiographic stage of healing also was significantly accelerated in the treatment group.

Heckman and colleagues performed a double-blind RCT comparing ultrasound treatment (n=33) with a placebo-control device (n=34) in closed or grade-I open fractures of the tibial shaft. (7) Treatment was started within 7 days after the fracture and consisted of one 20-minute period each day. Time-to-healing was 86 days in the treatment group versus 114 days in the control group (p=0.01), and time to overall (clinical and radiographic) healing was 96 days in the active-treatment group compared to 154 days in the control group (p=0.0001). Scaphoid fractures were treated with ultrasound in a study done in Germany. (8) Fifteen patients were randomly assigned to treatment and 15 to placebo device groups. Healing was assessed by computed tomography (CT) scans every 2 weeks. Fractures treated with ultrasound healed in 43.2 days versus 62 days in the control group (p<0.01). Pooled data from these studies demonstrated a mean reduction in radiographic healing time of 36.9% (95% CI: 25.6% to 46.0%).

Authors of another study included in the 2009 systematic review observed that the clinical relevance of accelerated radiologic healing has not been described and examined the effect of low-intensity pulsed ultrasound on fracture healing issues such as pain, function, and resumption of professional and personal activities. (9) They performed a multicenter double-blind RCT of ultrasound treatment of fresh clavicle fractures. Patients were taught to use the ultrasound devices for 20 minutes each day for 28 days and to record daily their subjective feeling as to whether the fracture healed or not (the primary outcome measure), pain on visual analogue scale (VAS), level of daily activities once a day expressed as hours of activity (work, household work, sport), and analgesic use. A total of 120 patients (61 active and 59 placebo) started study treatment. Nine patients in the active group and 10 in the placebo group were excluded from analysis because of incomplete follow-up or early withdrawal from the study. The day that the fracture clinically healed according to patient perception was determined in 92 patients (47 active and 45 placebo), and mean duration of time to clinical healing was 26.77 days in the active group versus 27.09 days in the placebo group. Between-group differences in analgesic use and mean VAS were not significant.

RCTs of Open Fractures. For the treatment of open fractures, the data are conflicting regarding the efficacy of ultrasonic accelerated fracture healing system (UAFHS), specifically those treated surgically with placement of an intramedullary nail. For example, Emami and colleagues conducted a study that randomly assigned 32 patients with a fresh tibial fracture that was fixed with an intramedullary rod to undergo additional treatment with an active or inactive ultrasound device. (10) The time-to-healing was not significantly different in the 2 groups, and the authors concluded that there was no benefit in operatively treated fractures. In contrast, Leung and colleagues reported on the results of a study that randomly assigned 30 fractures in 28 patients with complex tibial fractures treated with internal or external fixation to receive or not receive additional treatment with low-intensity ultrasound. (11) Based on radiologic assessment, the time to callus formation was significantly less in those in the ultrasound group. Due to the inconsistent results in the 2 small randomized studies, and the negative results of the meta-analysis, low-intensity ultrasound is considered investigational for open fractures.

Conclusions. There is some RCT evidence that ultrasound treatment improves radiographic healing for closed fresh fractures, but this finding is not consistent for studies of open fresh fractures. A 2009 systematic review and meta-analysis of RCTs found moderate- to very low-quality evidence for low-intensity pulsed ultrasonography in accelerating functional recovery among patients with fracture. The systematic review concluded that large trials of high methodologic quality focusing on patient important outcomes such as quality of life and return to function are needed to determine whether ultrasound fracture healing devices provide important benefits to patients. A 2012 Cochrane review that did not distinguish between closed and open fractures reported that there was an improvement in time to healing when all studies were pooled but that this finding was not robust on further analyses. The Cochrane review did not find any evidence that ultrasound improves functional outcomes.

The current policy does not limit the use of the device to specific fracture sites. Depending on their function, bones are composed of a varying combination of cortical and trabecular bone. However, at the cellular level, the type of bone cannot be distinguished histologically. The expansion of the policy to include all bones regardless of the anatomic site is based on this histologic similarity of all bones; it is not anticipated that the efficacy of ultrasound-accelerated healing would vary according to the anatomic site and function of the bone.

Nonunions

The policy regarding nonunion of fractures is based on data presented to the FDA as part of the approval process for Sonic Accelerated Fracture Healing System (SAFHS®) as a treatment of fracture nonunions. The following data were reported and are included in the package insert for the device (12):

  • Data were collected on 74 cases of established nonunion with a mean fracture age of nearly 3 years. The principal outcome measure was the percentage of patients with healed nonunions, as determined clinically and by radiographic analysis. Each case served as its own control, based on the definition of nonunion that suggests that nonunions have a 0% probability of achieving a healed state without an intervention.
  • A total of 64 of 74 cases (86%) were healed with use of low-intensity ultrasound. The time-to-healing was 173 days. The healed rate of scaphoid bones was lower, at 33% (2 of 6 cases), which was partially responsible for a significant difference between the healing rates of long bones (92%) versus other bones (67%).
  • Fracture age also affected healing rates, with fractures over 5 years-old having a healing rate of 50% compared to a healing rate of 95% in those present for no more than 1 year.

A study used prospectively defined criteria for analysis of all Dutch patients (96 participating clinics) who had been treated with ultrasound for established nonunion of the tibia (characterized by a total stop of all fracture repair processes). (13) Included in the analysis were 71 patients who were at least 3 months from the last surgical intervention and did not show any healing improvements in the 3 months before ultrasound treatment (average fracture age: 257 days; range: 180–781 days). All patients were followed up (average 2.7 years) by questionnaire, or by phone, if needed. There was an overall healing rate of 73%, at an average 184 days to healing (range: 52–739 days). No difference in healing rate for open or closed fractures was observed.

Delayed Union

In 2010, Schofer et al. reported an industry-sponsored multicenter randomized double-blinded sham-controlled trial of low-intensity pulsed ultrasound in 101 patients with delayed union of the tibia. (14) Delayed union was defined as lack of clinical and radiologic evidence of union, bony continuity, or bone reaction at the fracture site for no less than 16 weeks from the index injury or the most recent intervention. Roughly one third of the patients had an open fracture. Fifty-one patients were randomized to daily treatment with ultrasound, and 50 were assigned to an inactive sham device (20 minutes daily for 16 weeks). The primary outcome measure was the change in bone mineral density (BMD) over the 16 weeks, assessed by computed tomography (CT) attenuation coefficients, or Hounsfield units (Hus). Gap area at the fracture site was a secondary endpoint. The primary analysis was intention-to-treat with imputation of missing values (24% of sham-treated subjects and 9.8% of active-treated subjects were missing post-treatment values). The mean improvement in BMD was 1.34 (90% CI: 1.14 to 1.57) times greater for ultrasound-treated subjects compared to sham. Analysis of ‘completers’ showed a medium effect size (0.53) of the treatment. A mean reduction in bone gap area also favored ultrasound treatment, with a mean change of log gap area of -0.131 mm2 for the active treatment and -0.097 mm2 for sham (effect size of -0.47, 95% CI: -0.91 to -0.03). Untransformed data showed a difference between groups of -0.457 mm2 (90% CI: -0.864 to -0.049), which was statistically significant by a 1-sided test. The clinical significance of this difference is unclear. There was a trend (p=0.07) for more subjects receiving low-intensity pulsed ultrasound to be judged to be healed by the participating physicians by the end of the 16-week study period, 65% (33 of 51) of ultrasound versus 46% (23 of 50) sham subjects. While there was not a statistically significant improvement in the rate of healing, the improvements in intermediate outcomes and the corroborating evidence from trials of patients with similar indications, e.g., fracture nonunion, make it very likely that this treatment is efficacious for delayed union.

Distraction Osteogenesis

The 2009 systematic review by Busse et al. found 3 trials of distraction osteogenesis that used a variety of surrogate outcome measures with inconsistent results and provided very low-quality evidence of accelerated functional improvement. (4) In 2011, a small (n=36) nonblinded RCT of low-intensity pulsed ultrasound found no significant differences between the active and control groups in efficacy measures, although the treatment period (fixator gestation period) was decreased by more than a month. (15) Double-blind trials with a larger number of subjects are needed to evaluate the health benefits of this procedure.

Clinical Input Received Through Physician Specialty Societies and Academic Medical Centers

While the various physician specialty societies and academic medical centers may collaborate with and make recommendations during this process through the provision of appropriate reviewers, input received does not represent an endorsement or position statement by the physician specialty societies or academic medical centers, unless otherwise noted.

2008

In response to requests for input from physician specialty societies and academic medical centers for the 2008 policy update, input was received from 1 physician specialty society while this policy was under review. Physician input obtained through the American Academy of Orthopaedic Surgeons agreed with the positions regarding the criteria for medical necessity and the conditions that are considered investigational (e.g., delayed union and open/unstable grade II or III fractures).

2011

In response to requests, input was received through 2 physician specialty societies and 1 academic medical center for the policy review in January 2011. Input supported the use of ultrasound for nonunion and for fresh closed fractures at high risk for delayed fracture healing or nonunion as described in the policy. Onereviewer supported including chemotherapy, immunosuppressive agents, history of infection, Charcot neuroarthropathy, and fractures of the tibial shaft or clavicle as additional risk factors, and a different reviewer supported including fractures of the talus and sesamoids as additional risk factors.

2012

In response to requests, input was received through 4 academic medical centers for the policy review in December 2012. Input supported the use of low-intensity ultrasound in delayed union and nonunion of bones excluding the skull and vertebra, and in fresh closed fractures at high risk for delayed fracture healing or nonunion. Input agreed that other applications of low-intensity ultrasound treatment are investigational, including, but not limited to, treatment of congenital pseudoarthroses, open fractures, stress fractures, arthrodesis or failed arthrodesis. Additional risk factors were noted, including: use of anticoagulants, immunosuppressive drugs or chemotherapy; infection at the fracture site; severe anemia; obesity; and fracture locations more prone to nonunion such as tibial and distal radial fractures.

Ongoing trials

The Trial to Evaluate Ultrasound in the Treatment of Tibial Fractures (TRUST) (NCT00667849) is an ongoing trial of low-intensity ultrasound for tibial fractures. This is a double-blind trial with sham ultrasound control, and is scheduled to enroll 500 patients. The primary outcome measure is radiographic healing at up to one year, and a secondary outcome is the rate of fracture non-union. The trial is scheduled for completion in December 2012.

Summary

There is evidence from published studies that ultrasound improves healing rates in closed fresh fractures, delayed union, and fracture nonunion. As a result, ultrasound may be considered medically necessary for these indications. For treatment of open, fresh fractures, the evidence is less consistent across RCTs, and systematic reviews do not report strong conclusions on efficacy of ultrasound for improving healing when data on closed and open fresh fractures are combined. Most fresh closed fractures heal without complications with the use of standard fracture care, i.e., closed reduction and cast immobilization. Therefore, the most appropriate candidates for ultrasound treatment may be those with closed fractures at high risk for delayed fracture healing or nonunion. Based on the available evidence and support from clinical input, low intensity ultrasound treatment may be considered medically necessary for fresh fractures (closed), delayed union of fractures, and nonunion of fractures.

Evidence is insufficient to evaluate health outcomes with use of low-intensity ultrasound as a treatment of congenital pseudarthroses, arthrodesis of the appendicular skeleton, or spinal fusions. Use of ultrasound for these conditions is considered investigational. Based on one small trial with results showing no benefit to use of ultrasound treatment in the treatment of stress fractures, this is considered investigational.

Practice Guidelines and Position Statements

In 2010, the United Kingdom’s National Institute for Health and Clinical Excellence (NICE) concluded that current evidence on the efficacy of low-intensity pulsed ultrasound to promote fracture healing is adequate to show that this procedure can reduce fracture healing time and gives clinical benefit, particularly in circumstances of delayed healing and fracture non-union. (16)

The American Academy of Orthopaedic Surgeons (AAOS) has published 2009 guidelines on the treatment of distal radius fractures. (17) The AAOS provided a weak recommendation for use of ultrasound for adjuvant treatment of distal radius fractures. This recommendation was based results from 2 studies that used non-validated patient outcome measures.

Medicare National Coverage

Effective January 1, 2001, ultrasonic osteogenic stimulators are covered as medically reasonable and necessary for the treatment of nonunion fractures. (18) Nonunion fractures of the skull, vertebrae, and those that are tumor-related are excluded from coverage. Ultrasonic osteogenic stimulators may not be used concurrently with other non-invasive osteogenic devices. Ultrasonic osteogenic stimulators for fresh fractures and delayed unions remain non-covered.

References:

 

  1. Bhandari M, Fong K, Sprague S et al. Variability in the definition and perceived causes of delayed unions and nonunions: a cross-sectional, multinational survey of orthopaedic surgeons. J Bone Joint Surg Am 2012; 94(15):e1091-6.
  2. Blue Cross and Blue Shield Association Technology Evaluation Center (TEC). Ultrasound accelerated fracture healing. TEC Assessments 1995; Volume 10, Tab 14.
  3. Busse JW, Bhandari M, Kulkarni AV et al. The effect of low-intensity pulsed ultrasound therapy on time to fracture healing: a meta-analysis. CMAJ 2002; 166(4):437-41.
  4. Busse JW, Kaur J, Mollon B et al. Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials. BMJ 2009; 338:b351.
  5. Griffin XL, Smith N, Parsons N et al. Ultrasound and shockwave therapy for acute fractures in adults. Cochrane Database Syst Rev 2012; 2:CD008579.
  6. Kristiansen TK, Ryaby JP, McCabe J et al. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound. A multicenter, prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am 1997; 79(7):961-73.
  7. Heckman JD, Ryaby JP, McCabe J et al. Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg Am 1994; 76(1):26-34.
  8. Lubbert PH, van der Rijt RH, Hoorntje LE et al. Low-intensity pulsed ultrasound (LIPUS) in fresh clavicle fractures: a multi-centre double blind randomised controlled trial. Injury 2008; 39(12):1444-52.
  9. Rue JP, Armstrong DW, 3rd, Frassica FJ et al. The effect of pulsed ultrasound in the treatment of tibial stress fractures. Orthopedics 2004; 27(11):1192-5.
  10. Emami A, Petren-Mallmin M, Larsson S. No effect of low-intensity ultrasound on healing time of intramedullary fixed tibial fractures. J Orthop Trauma 1999; 13(4):252-7.
  11. Leung KS, Lee WS, Tsui HF et al. Complex tibial fracture outcomes following treatment with low-intensity pulsed ultrasound. Ultrasound Med Biol 2004; 30(3):389-95.
  12. Summary of Safety and Effectiveness Data. Exogen 2000® or Sonic Accelerated Fracture Healing System (SAFHS®) Exogen®, a Smith and Nephew Company, Piscataway, NJ.
  13. Rutten S, Nolte PA, Guit GL et al. Use of low-intensity pulsed ultrasound for posttraumatic nonunions of the tibia: a review of patients treated in the Netherlands. J Trauma 2007; 62(4):902-8.
  14. Schofer MD, Block JE, Aigner J et al. Improved healing response in delayed unions of the tibia with low-intensity pulsed ultrasound: results of a randomized sham-controlled trial. BMC Musculoskelet Disord 2010; 11:229.
  15. Dudda M, Hauser J, Muhr G et al. Low-intensity pulsed ultrasound as a useful adjuvant during distraction osteogenesis: a prospective, randomized controlled trial. J Trauma 2011; 71(5):1376-80.
  16. National Institute for Health and Clinical Excellence. Low-intensity pulsed ultrasound to promote fracture healing. 2010. Available online at: http://www.nice.org.uk/nicemedia/live/12408/52076/52076.pdf. Last accessed September, 2012.
  17. American Academy of Orthopaedic Surgeons. The treatment of distal radius fractures. 2009. Available online at: http://www.aaos.org/research/guidelines/drfguideline.pdf. Last accessed November, 2012.
  18. Centers for Medicare and Medicaid Services. National Coverage Decision for Osteogenic Stimulators (150.2) 2005. Available online at: http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=150.2&ncd_version=2&basket=ncd%3A150%2E2%3A2%3AOsteogenic+Stimulators. Last accessed September, 2012.

Codes

Number

Description

CPT 

20979 

Low-intensity ultrasound stimulation to aid bone healing, non-invasive (nonoperative) 

ICD-9 Procedure 

99.86 

Non-invasive placement of bone growth stimulator 

ICD-9 Diagnosis 

733.82 

Fracture nonunion 

 

810 – 829 

Fracture code range. Even 4th digit indicates closed fracture, odd 4th digit indicates open fracture. Fifth digit subclassification is required with several of the fracture codes 

   905.0-905.5 Late effects of fracture code range
   V54.10-V54.19 Aftercare for healing traumatic fracture

HCPCS 

E0760 

Osteogenesis stimulator, low-intensity ultrasound 

ICD-10-CM (effective 10/1/14) S42.00xA - S42.92xA;
S49.00xA - S49.199A;
S52.00xA - S52.92xA;
S59.00xA - S59.299A;
S62.00xA - S62.92xA;
S72.00xA - S72.92xA;
S79.00xA - S79.199A;
S82.00xA - S82.92xA;
S89.00xA - S89.399A;
S92.00xA - S92.919A
Fracture codes – 7th digit “A,” as shown in the list, is initial encounter for closed fracture. The same codes with 7th digit “K” is subsequent encounter for nonunion (in forearm, femur, lower leg & ankle fractures 7th digits “M” and “N” are also nonunion for certain types of open fractures – in fractures of the shoulder, humerus, wrist, hand and foot there isn’t separation of open vs. closed nonunions). This list does not include any skull or vertebral fracture codes. There are also other codes for pathological and stress fractures (M80 – M84) which are not listed here.
ICD-10-PCS (effective 10/1/14)   ICD-10-PCS codes are only used for inpatient services.
  3E00XGC Administration, physiological systems and anatomical regions, introduction, skin and mucous membranes, external, other therapeutic substance

Type of Service 

DME 

Place of Service 

Outpatient, Home 


Index

Device, Fracture Healing
Fracture Healing, Ultrasound
Ultrasound Accelerated Fracture Healing Device


Policy History

Date Action Reason

12/01/95

Add to Durable Medical section

New policy

07/16/99

Replace policy

Updated; new indications

11/01/99

Replace policy

New CPT code; policy unchanged

08/18/00

Replace policy

New indication for treatment of fracture nonunions

12/15/00

Replace policy

Editorial revisions; policy statement unchanged

12/18/02

Replace policy

Policy updated; new references added; policy statement unchanged

02/25/04

Replace policy

Policy updated with literature review; policy statement unchanged

04/1/05

Replace policy

Policy updated with literature review; policy statement revised to explicitly state that ultrasound treatment of open fracture is investigational. Information on Medicare policy added. Reference Nos. 5 and 6 added.

06/27/05

Replace policy

Policy updated with literature review for November 2004 through May 2005 and new Medicare coverage decision; policy statement unchanged.

10/10/06

Replace policy

Policy updated with literature search from May 2005 through July 2006. Policy statement unchanged.

02/14/08 Replace policy Policy updated with literature review; references 7–8 added; policy statements unchanged
09/10/09 Replace policy Policy updated with literature search, rationale extensively edited, references 7 to 10 and 12 added. One reference removed. No change to existing policy statements; use in stress fractures added as investigational
01/13/11 Replace policy Policy updated with literature search, clinical input reviewed, references reordered, policy statements modified by moving information from policy guidelines to policy statements about risk factors for nonunion
9/01/11 Replace policy Policy updated with literature search through July 2011; references 12 and 13 added; treatment of delayed unions considered medically necessary.
09/13/12 Replace policy Policy updated with literature search through July 2012; references 1, 5, 15 added; arthrodesis added to investigational statement; definition of delayed unions revised to 3 months for consistency with definition of nonunion.
12/13/12 Replace Policy
Clinical input reviewed; reference 17 added; policy statements unchanged